Good bioavailability of desmopressin can be obtained by means of an
orodispersible pharmaceutical dosage form. Preferred dosage forms
comprise desmopressin and an open matrix network which is an inert
water-soluble or water-dispersible carrier material. Desmopressin
formulated in this way is useful for voiding postponement, or the
treatment or prevention of incontinence, primary nocturnal enuresis
(PNE), nocturia or central diabetes insipidus. Peptides other than
desmopressin can also be formulated in this way.